P/B
2,8
Zevra Therapeutics
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
$610.5M
Market Cap • 10/30/2026
2006
(20 years)
Founded
2015
(11 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
4,5
P/EBITDA
7,4
P/OCF
—
P/FCF
—
P/E
11,2
BVPS
3,7
EPS
1
Market Cap
Market Cap
610,5M
EV
390,4M
EV/Revenue
2,9
EV/EBITDA
4,7
EV/EBIT
4,7
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
-375,4M
Profitability
Gross Margin
97,7%
EBITDA Margin
61%
EBIT Margin
60,5%
Net Margin
42,8%
D&A/EBITDA
0,8%
R&D/Revenue
4,4%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
39,3%
% PPE
0,8%
% Goodwill
1,6%
ROE
34,5%
ROIC
199,7%
Growth
CAGR Revenue 5Y
36,8%
CAGR Op. Income 5Y
58%
CAGR OCF 5Y
-100%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
5,2
Quick Ratio
5
Interest Coverage
1442,8%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!